| Application number | Title of the application | Filing Date | Status |
|---|
Array
(
[id] => 714422
[patent_doc_number] => 07052672
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2006-05-30
[patent_title] => 'Stabilized radiopharmaceutical compositions'
[patent_app_type] => utility
[patent_app_number] => 10/465974
[patent_app_country] => US
[patent_app_date] => 2001-04-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 5
[patent_no_of_words] => 6440
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 43
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/052/07052672.pdf
[firstpage_image] =>[orig_patent_app_number] => 10465974
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/465974 | Stabilized radiopharmaceutical compositions | Apr 10, 2001 | Issued |
Array
(
[id] => 6934222
[patent_doc_number] => 20010055566
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2001-12-27
[patent_title] => 'Method for viewing tumor tissue located within a body cavity'
[patent_app_type] => new
[patent_app_number] => 09/832297
[patent_app_country] => US
[patent_app_date] => 2001-04-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10094
[patent_no_of_claims] => 39
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 110
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0055/20010055566.pdf
[firstpage_image] =>[orig_patent_app_number] => 09832297
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/832297 | Method for viewing tumor tissue located within a body cavity | Apr 8, 2001 | Issued |
Array
(
[id] => 1395052
[patent_doc_number] => 06534038
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2003-03-18
[patent_title] => 'Ternary ligand complexes useful as radiopharmaceuticals'
[patent_app_type] => B2
[patent_app_number] => 09/826449
[patent_app_country] => US
[patent_app_date] => 2001-04-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18932
[patent_no_of_claims] => 47
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 495
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/534/06534038.pdf
[firstpage_image] =>[orig_patent_app_number] => 09826449
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/826449 | Ternary ligand complexes useful as radiopharmaceuticals | Apr 4, 2001 | Issued |
Array
(
[id] => 6223845
[patent_doc_number] => 20020004032
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-01-10
[patent_title] => 'Macrocyclic chelants for metallopharmaceuticals'
[patent_app_type] => new
[patent_app_number] => 09/826549
[patent_app_country] => US
[patent_app_date] => 2001-04-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22179
[patent_no_of_claims] => 39
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 5
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0004/20020004032.pdf
[firstpage_image] =>[orig_patent_app_number] => 09826549
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/826549 | Macrocyclic chelants for metallopharmaceuticals | Apr 4, 2001 | Issued |
Array
(
[id] => 6156603
[patent_doc_number] => 20020146370
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-10-10
[patent_title] => 'USE OF PROTEIN TYROSINE PHOSPHATASE ZETA AS A BIOMOLECULAR TARGET IN THE TREATMENT AND VISUALIZATION OF BRAIN TUMORS'
[patent_app_type] => new
[patent_app_number] => 09/816703
[patent_app_country] => US
[patent_app_date] => 2001-03-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 12199
[patent_no_of_claims] => 67
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 41
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0146/20020146370.pdf
[firstpage_image] =>[orig_patent_app_number] => 09816703
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/816703 | Use of protein tyrosine phosphatase zeta as a biomolecular target in the treatment and visualization of brain tumors | Mar 22, 2001 | Issued |
Array
(
[id] => 6641618
[patent_doc_number] => 20030103896
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-06-05
[patent_title] => 'Methods of synthesis and use of radiolabelled platinum chemotherapeutic agents'
[patent_app_type] => new
[patent_app_number] => 10/239363
[patent_app_country] => US
[patent_app_date] => 2002-12-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5649
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0103/20030103896.pdf
[firstpage_image] =>[orig_patent_app_number] => 10239363
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/239363 | Methods of synthesis and use of radiolabelled platinum chemotherapeutic agents | Mar 22, 2001 | Issued |
| 09/810450 | Technetium 99m-N2S2- congo red complexes utilizing diamide dithiolate ligand systems for radioimaging | Mar 18, 2001 | Abandoned |
Array
(
[id] => 1367046
[patent_doc_number] => 06562364
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2003-05-13
[patent_title] => 'Desmethylselegiline enantiomers and their use to treat drug withdrawal symptoms'
[patent_app_type] => B2
[patent_app_number] => 09/805281
[patent_app_country] => US
[patent_app_date] => 2001-03-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 20
[patent_no_of_words] => 12785
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 62
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/562/06562364.pdf
[firstpage_image] =>[orig_patent_app_number] => 09805281
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/805281 | Desmethylselegiline enantiomers and their use to treat drug withdrawal symptoms | Mar 12, 2001 | Issued |
Array
(
[id] => 1366363
[patent_doc_number] => 06562319
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2003-05-13
[patent_title] => 'Radiolabeled irreversible inhibitors of epidermal growth factor receptor tyrosine kinase and their use in radioimaging and radiotherapy'
[patent_app_type] => B2
[patent_app_number] => 09/802928
[patent_app_country] => US
[patent_app_date] => 2001-03-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 4
[patent_no_of_words] => 15092
[patent_no_of_claims] => 40
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 258
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/562/06562319.pdf
[firstpage_image] =>[orig_patent_app_number] => 09802928
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/802928 | Radiolabeled irreversible inhibitors of epidermal growth factor receptor tyrosine kinase and their use in radioimaging and radiotherapy | Mar 11, 2001 | Issued |
Array
(
[id] => 6921392
[patent_doc_number] => 20010028877
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2001-10-11
[patent_title] => ' Polymeric contrast agents for characterizing tumor angiogenesis in medicalimaging'
[patent_app_type] => new
[patent_app_number] => 09/792177
[patent_app_country] => US
[patent_app_date] => 2001-02-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 5851
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 27
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0028/20010028877.pdf
[firstpage_image] =>[orig_patent_app_number] => 09792177
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/792177 | Polymeric contrast agents for characterizing tumor angiogenesis in medicalimaging | Feb 22, 2001 | Issued |
Array
(
[id] => 6876881
[patent_doc_number] => 20010007034
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2001-07-05
[patent_title] => 'Tetrahydrofuran-adducted Group II beta-diketonate complexes as source reagents for chemical vapor deposition'
[patent_app_type] => new-utility
[patent_app_number] => 09/791005
[patent_app_country] => US
[patent_app_date] => 2001-02-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 4552
[patent_no_of_claims] => 33
[patent_no_of_ind_claims] => 12
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0007/20010007034.pdf
[firstpage_image] =>[orig_patent_app_number] => 09791005
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/791005 | Tetrahydrofuran-adducted group II -diketonate complexes as source reagents for chemical vapor deposition | Feb 21, 2001 | Issued |
Array
(
[id] => 1405623
[patent_doc_number] => 06524552
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2003-02-25
[patent_title] => 'Contrast agents'
[patent_app_type] => B2
[patent_app_number] => 09/785177
[patent_app_country] => US
[patent_app_date] => 2001-02-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 20127
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 5
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/524/06524552.pdf
[firstpage_image] =>[orig_patent_app_number] => 09785177
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/785177 | Contrast agents | Feb 19, 2001 | Issued |
| 09/763777 | Imaging with tc-99m labeled fibrin-alpha-chain peptide | Feb 15, 2001 | Abandoned |
Array
(
[id] => 5845349
[patent_doc_number] => 20020132811
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-09-19
[patent_title] => '2,7-substituted octahydro-1H-pyrido[1,2-A]pyrazine derivatives as ligands for serotonin receptors'
[patent_app_type] => new
[patent_app_number] => 09/784567
[patent_app_country] => US
[patent_app_date] => 2001-02-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23891
[patent_no_of_claims] => 36
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0132/20020132811.pdf
[firstpage_image] =>[orig_patent_app_number] => 09784567
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/784567 | 2,7-substituted octahydro-1H-pyrido[1,2-A]pyrazine derivatives as ligands for serotonin receptors | Feb 14, 2001 | Abandoned |
Array
(
[id] => 1265359
[patent_doc_number] => 06656448
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2003-12-02
[patent_title] => 'Matrix metalloproteinase inhibitors'
[patent_app_type] => B1
[patent_app_number] => 09/783249
[patent_app_country] => US
[patent_app_date] => 2001-02-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 34773
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 541
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/656/06656448.pdf
[firstpage_image] =>[orig_patent_app_number] => 09783249
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/783249 | Matrix metalloproteinase inhibitors | Feb 13, 2001 | Issued |
Array
(
[id] => 6402847
[patent_doc_number] => 20020037268
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-03-28
[patent_title] => 'Antimicrobial sanitizing lotion with skin protection properties'
[patent_app_type] => new
[patent_app_number] => 09/782676
[patent_app_country] => US
[patent_app_date] => 2001-02-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3874
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0037/20020037268.pdf
[firstpage_image] =>[orig_patent_app_number] => 09782676
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/782676 | Antimicrobial sanitizing lotion with skin protection properties | Feb 12, 2001 | Issued |
Array
(
[id] => 5800954
[patent_doc_number] => 20020009491
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-01-24
[patent_title] => 'Compositions and methods for enhancing drug delivery across biological membranes and tissues'
[patent_app_type] => new
[patent_app_number] => 09/779693
[patent_app_country] => US
[patent_app_date] => 2001-02-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 13271
[patent_no_of_claims] => 40
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 54
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0009/20020009491.pdf
[firstpage_image] =>[orig_patent_app_number] => 09779693
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/779693 | Compositions and methods for enhancing drug delivery across biological membranes and tissues | Feb 6, 2001 | Abandoned |
Array
(
[id] => 1586992
[patent_doc_number] => 06359120
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-03-19
[patent_title] => 'Rhenium and technetium complexes containing a hypoxia-localizing moiety'
[patent_app_type] => B1
[patent_app_number] => 09/778969
[patent_app_country] => US
[patent_app_date] => 2001-02-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 31240
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 89
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/359/06359120.pdf
[firstpage_image] =>[orig_patent_app_number] => 09778969
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/778969 | Rhenium and technetium complexes containing a hypoxia-localizing moiety | Feb 4, 2001 | Issued |
Array
(
[id] => 1403527
[patent_doc_number] => 06538115
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2003-03-25
[patent_title] => 'Phosphorus supported carbene transition metal complexes'
[patent_app_type] => B2
[patent_app_number] => 09/770979
[patent_app_country] => US
[patent_app_date] => 2001-01-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7488
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 431
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/538/06538115.pdf
[firstpage_image] =>[orig_patent_app_number] => 09770979
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/770979 | Phosphorus supported carbene transition metal complexes | Jan 25, 2001 | Issued |
Array
(
[id] => 6892283
[patent_doc_number] => 20010018445
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2001-08-30
[patent_title] => 'Pharmaceutical composition for the treatment of hepatocellular carcinoma'
[patent_app_type] => new
[patent_app_number] => 09/768442
[patent_app_country] => US
[patent_app_date] => 2001-01-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 1869
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 24
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0018/20010018445.pdf
[firstpage_image] =>[orig_patent_app_number] => 09768442
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/768442 | Pharmaceutical composition for the treatment of hepatocellular carcinoma | Jan 23, 2001 | Abandoned |